Profile for Japan Patent: 6077053
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Japan Patent: 6077053
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
⤷ Sign Up | May 15, 2029 | Vivus | QSYMIA | phentermine hydrochloride; topiramate |
⤷ Sign Up | Jun 14, 2029 | Vivus | QSYMIA | phentermine hydrochloride; topiramate |
⤷ Sign Up | Jun 9, 2028 | Vivus | QSYMIA | phentermine hydrochloride; topiramate |
⤷ Sign Up | Jun 9, 2028 | Vivus | QSYMIA | phentermine hydrochloride; topiramate |
⤷ Sign Up | Jun 9, 2028 | Vivus | QSYMIA | phentermine hydrochloride; topiramate |
⤷ Sign Up | Jun 9, 2028 | Vivus | QSYMIA | phentermine hydrochloride; topiramate |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |